Pay in 4 interest-free payments of $6.18 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
Brand-name medications (Wegovy, Zepbound) are FDA approved and manufactured by Novo Nordisk and Eli Lilly
With these successes, momentum is building to identify novel and more effective treatment strategies for obesity
Like other drugs that suppress the aldosterone pathway, Baxdrostat can increase the risk of hyperkalemia, making potassium monitoring important
Program includes: GLP-1 medication when prescribed Weekly weigh-ins Monthly nutrition guidance Body composition tracking using InBody Ongoing medical supervision This option is designed for individuals seeking medical weight management with a focus on safety, sustainability, and long-term metabolic health
